Republication de : L’embolie pulmonaire aux urgences : que disent les recommandations ?

Laporte, 2008, Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: findings from the Registro Informatizado de la Enfermedad TromboEmbolicavenosa (RIETE) Registry, Circulation, 117, 1711, 10.1161/CIRCULATIONAHA.107.726232 Goldhaber, 1999, Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER), Lancet, 353, 1386, 10.1016/S0140-6736(98)07534-5 Konstantinides, 2014, 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism, Eur Heart J, 35, 3033, 10.1093/eurheartj/ehu283 Righini, 2014, Age-adjusted d-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study, JAMA, 311, 1117, 10.1001/jama.2014.2135 Righini, 2008, Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial, Lancet, 371, 1343, 10.1016/S0140-6736(08)60594-2 Jimenez, 2010, Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism, Arch Intern Med, 170, 1383, 10.1001/archinternmed.2010.199 Schulman, 2009, Dabigatran versus warfarin in the treatment of acute venous thromboembolism, N Engl J Med, 361, 2342, 10.1056/NEJMoa0906598 Buller, 2012, Oral rivaroxaban for the treatment of symptomatic pulmonary embolism, N Engl J Med, 366, 1287, 10.1056/NEJMoa1113572 Agnelli, 2013, Oral apixaban for the treatment of acute venous thromboembolism, N Engl J Med, 369, 799, 10.1056/NEJMoa1302507 Buller, 2013, Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism, N Engl J Med, 369, 1406, 10.1056/NEJMoa1306638 Marti, 2015, Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis, Eur Heart J, 36, 605, 10.1093/eurheartj/ehu218 Meyer, 2014, Fibrinolysis for patients with intermediate-risk pulmonary embolism, N Engl J Med, 370, 1402, 10.1056/NEJMoa1302097 Meneveau, 2018, Outcomes after Extracorporeal membrane oxygenation for the treatment of high-risk pulmonary embolism: a multicentre series of 52 cases, Eur Heart J, 10.1093/eurheartj/ehy464 Barco, 2016, Home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban. Rationale and design of the HoT-PE Trial, Thromb Haemost, 116, 191, 10.1160/TH16-01-0004